...
ZEPPMID

Zepp Health Corporation

TechnologyConsumer Electronics
$19.28
$0.02(-12.76%)
52W$2.13
$61.85
FinancialsValuationvs VUZI
Updated Mar 2, 12:00 AM
RSI48
RS Rating96/99
Beta1.22
Volatility153%
F-Score2/9
Mkt Cap$2.3B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Zepp Health Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 96), indicating clear outperformance against the broad market. Earnings growth of 80% provides fundamental context to the price action. Investors should exercise caution due to high volatility (153% annualized), which requires wider risk management.

Relative Strength
96
out of 99
Market Leader
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.22
vs S&P 500
ABOVE MKT
52W Position
29%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$23.83
50 SMA > 100 SMA$29.90
100 SMA > 150 SMA$33.14
150 SMA > 200 SMA$26.07

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$21.10-8.62%BELOW
50 SMA$23.83-19.10%BELOW
100 SMA$29.90-35.51%BELOW
150 SMA$33.14-41.83%BELOW
200 SMA$26.07-26.04%BELOW

Price Performance

1D-12.8%
1W-15.4%
1M-13.2%
3M-28.5%
6M-49.2%
YTD-31.2%
1Y+6.2%
3Y+41.8%
52-Week Trading Range29% from low
$19.28
52W Low$2.13
52W High$61.85

Technical Indicators

RSI (14)NEUTRAL
48.1
305070
VCP ScoreCOOL
4/10
Base depth: 90.7%

Risk Profile

Beta
1.22
52W Vol
153%
ATR
$2.41
Max DD (1Y)
-73%

Volume Analysis

Today
19
50D Avg
120.2K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24-24700%
$-66.96
Q1'25-831%
$-35.76
Q2'25+28%
$-14.00
Q3'25+80%
$-4.56
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:-25.46%
3 Years:-39.99%
TTM:+13.95%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:-160.76%

Stock Price CAGR

10 Years:-8.13%
5 Years:-22.58%
3 Years:+41.81%
1 Year:+6.22%

Return on Equity

10Y Avg:5.3%
5Y Avg:-6.3%
3Y Avg:-14.9%
Last Year:-29.7%

Key Metrics

Market Cap$2.3B
Gross Margin38.5%
Net Margin-41.6%
Piotroski F-Score2/9

More ZEPP Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ZEPP vs VUZIVUZIWLDS

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 96 meansZEPP outperformed 96% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 1.22 means 22% more volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 2/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 4/10 with COOL status.

Frequently Asked Questions

Is ZEPP in an uptrend right now?

ZEPP has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is ZEPP overbought or oversold?

ZEPP's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.

Is ZEPP outperforming the market?

ZEPP has a Relative Strength (RS) Rating of 96 out of 99. Yes, ZEPP is a market leader, outperforming 96% of all stocks over the past 12 months.

Where is ZEPP in its 52-week range?

ZEPP is trading at $19.28, which is 31% of its 52-week high ($61.85) and 29% above its 52-week low ($2.13).

How volatile is ZEPP?

ZEPP has a Beta of 1.22 and 52-week volatility of 153%. It's more volatile than the S&P 500 - expect bigger swings.